No Data
No Data
TScan Therapeutics Director Buys $26,450 in Company Stock
TScan Therapeutics to Participate in Upcoming Investor Conferences
Director of TScan Therapeutics Barbara Klencke Buys 18% More Shares
Morgan Stanley Initiates TScan Therapeutics(TCRX.US) With Buy Rating, Announces Target Price $14
Barclays Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $14
H.C. Wainwright Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $15
No Data
No Data